[1]
|
Alicic, R.Z., Rooney, M.T. and Tuttle, K.R. (2017) Diabetic Kidney Disease: Challenges, Progress, and Possibilities. Clinical Journal of the American Society of Nephrology, 12, 2032-2045. https://doi.org/10.2215/CJN.11491116
|
[2]
|
Saeedi, P., et al. (2019) Global and Regional Diabetes Prevalence Estimates for 2019 and Projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th Edition. Diabetes Research and Clinical Practice, 157, Article ID: 107843. https://doi.org/10.1016/j.diabres.2019.107843
|
[3]
|
Zhang, L., Long, J., Jiang, W., Ying, S. and Wang, H. (2016) Trends in Chronic Kidney Disease in China. New England Journal of Medicine, 375, 905-906. https://doi.org/10.1056/NEJMc1602469
|
[4]
|
郑文, 潘少康, 刘东伟, 刘章锁. 糖尿病肾病治疗进展[J]. 中华肾脏病志, 2020, 36(6): 476-480.
|
[5]
|
Vaidya, V.S., Niewczas, M.A., Ficociello, L.H., Johnson, A.C., Collings, F.B., Warram, J.H., et al. (2011) Regression of Microalbuminuria in Type 1 Diabetes Is Associated with Lower Levels of Urinary Tubular Injury Biomarkers, Kidney Injury Molecule-1, and n-acetyl-β-d-glucosaminidase. Kidney International, 79, 464-470.
https://doi.org/10.1038/ki.2010.404
|
[6]
|
Jerums, G., Panagiotopoulos, S., Premaratne, E. and Macisaac, R.J. (2009) Integrating Albuminuria and gfr in the Assessment of Diabetic Nephropathy. Nature Reviews Nephrology, 5, 397. https://doi.org/10.1038/nrneph.2009.91
|
[7]
|
Kern, E., Erhard, P., Sun, W., Genuth, S. and Weiss, M.F. (2010) Early Urinary Markers of Diabetic Kidney Disease: A Nested Case-Control Study from the Diabetes Control and Complications Trial (DCCT). American Journal of Kidney Diseases, 55, 813-816. https://doi.org/10.1053/j.ajkd.2009.11.009
|
[8]
|
Chakraborty, S., et al. (2012) The Multifaceted Roles of Neutrophil Gelatinase Associated lipocalin (NGAL) in Inflammation and Cancer. Biochimica et Biophysica Acta (BBA)—Reviews on Cancer, 1826, 129-169.
https://doi.org/10.1016/j.bbcan.2012.03.008
|
[9]
|
Xiao, X., Yeoh, B.S. and Vijay-Kumar, M. (2017) Lipocalin 2: An Emerging Player in Iron Homeostasis and Inflammation. Annual Review of Nutrition, 37, 103-130. https://doi.org/10.1146/annurev-nutr-071816-064559
|
[10]
|
Rudd, P.M., Mattu, T.S., Masure, S., Bratt, T., Van, D., Wormald, M.R., et al. (1999) Glycosylation of Natural Human Neutrophil Gelatinase B and Neutrophil Gelatinase B-Associated Lipocalin. Biochemistry, 38, 13937-13950.
https://doi.org/10.1021/bi991162e
|
[11]
|
Kjeldsen, L., Johnsen, A.H., Sengelo, V.H. and Borregaard, N. (1993) Isolation and Primary Structure of NGAL, a Novel Protein Associated with Human Neutrophil Gelatinase. Journal of Biological Chemistry, 268, 10425-10432.
https://doi.org/10.1016/S0021-9258(18)82217-7
|
[12]
|
Mishra, J. (2003) Identification of Neutrophil Gelatinase-Associated Lipocalin as a Novel Early Urinary Biomarker for Ischemic Renal Injury. Journal of the American Society of Nephrology, 14, 2534.
https://doi.org/10.1097/01.ASN.0000088027.54400.C6
|
[13]
|
Haase, M., Bellomo, R. and Haase-Fielitz, A. (2010) Neutrophil Gelatinase-Associated Lipocalin. Current Opinion in Critical Care, 16, 526. https://doi.org/10.1097/MCC.0b013e328340063b
|
[14]
|
Temesgen, F. and Zemenu, T. (2016) Urinary Markers of Tubular Injury in Early Diabetic Nephropathy. International Journal of Nephrology, 2016, Article ID: 4647685.
|
[15]
|
Mori, K. and Nakao, K. (2007) Neutrophil Gelatinase-Associated Lipocalin as the Real-Time Indicator of Active Kidney Damage. Kidney International, 71, 967-970. https://doi.org/10.1038/sj.ki.5002165
|
[16]
|
Chou, K.M., Lee, C.C., Chen, C.H., Sun, C.Y. and Ashton, N. (2013) Clinical Value of NGAL, l-fabp and Albuminuria in Predicting GFR Decline in Type 2 Diabetes Mellitus Patients. PLoS ONE, 8, e54863.
https://doi.org/10.1371/journal.pone.0054863
|
[17]
|
Wu, J. (2013) Urinary TNF-Α and NGAL Are Correlated with the Progression of Nephropathy in Patients with Type 2 Diabetes. Experimental & Therapeutic Medicine, 6, 1482-1488. https://doi.org/10.3892/etm.2013.1315
|
[18]
|
Thorn, L.M., Gordin, D., Harjutsalo, V., Hgg, S., Masar, R., Saraheimo, M., et al. (2015) The Presence and Consequence of Nonalbuminuric Chronic Kidney Disease in Patients with Type 1 Diabetes. Diabetes Care, 38, 2128.
https://doi.org/10.2337/dc15-0641
|
[19]
|
Papadopoulou-Marketou, N., Skevaki, C., Kosteria, I., Peppa, M., Chrousos, G., Papassotiriou, I., et al. (2014) Ngal and Cystatin C: Two Possible Early Markers of Diabetic Nephropathy in Young Patients with Type 1 Diabetes Mellitus: One Year Follow Up. Hormones, 14, 232-240. https://doi.org/10.14310/horm.2002.1520
|
[20]
|
Thrailkill, K.M., Moreau, C.S., Cockrell, G.E., Jo, C.H., Bunn, R.C., et al. (2010) Disease and Gender-Specific Dysregulation of NGAL and mmp-9 in Type 1 Diabetes Mellitus. Endocrine, 37, 336-343.
https://doi.org/10.1007/s12020-010-9308-6
|
[21]
|
Fernandes, J.R., Ogurtsova, K., Linnenkamp, U., Guariguata, L., Seuring, T., Zhang, P., et al. (2016) IDF Diabetes Atlas Estimates of 2014 Global Health Expenditures on Diabetes. Diabetes Research & Clinical Practice, 117, 48-54.
https://doi.org/10.1016/j.diabres.2016.04.016
|
[22]
|
Espinel, E., Agraz, I., Ibernon, M., Ramos, N., Fort, J. and Seron, D. (2015) Renal Biopsy in Type 2 Diabetic Patients. Journal of Clinical Medicine, 4, 998-1009. https://doi.org/10.3390/jcm4050998
|
[23]
|
Phillips, A.O. and Steadman, R. (2002) Diabetic Nephropathy: The Central Role of Renal Proximal Tubular Cells in Tubulointerstitial Injury. Histology and Histopathology, 17, 247-252.
|
[24]
|
Gilbert, R.E. and Cooper, M.E. (1999) The Tubulointerstitium in Progressive Diabetic Kidney Disease: More than an Aftermath of Glomerular Injury? Kidney International, 56, 1627-1637.
https://doi.org/10.1046/j.1523-1755.1999.00721.x
|
[25]
|
Phillips, A.O. (2003) The Role of Renal Proximal Tubular Cells in Diabetic Nephropathy. Current Diabetes Reports, 3, 491-496. https://doi.org/10.1007/s11892-003-0013-1
|
[26]
|
Sarnak Mark, J., Bloom, R., Muntner, P., Rahman, M., Saland Jeffrey, M., Wilson Peter, W.F. and Fried, L. (2015) KDOQI US Commentary on the 2013 KDIGO Clinical Practice Guideline for Lipid Management in CKD. American Journal of Kidney Diseases, 65, 354-366. https://doi.org/10.1053/j.ajkd.2014.10.005
|
[27]
|
Veiga, G., Alves, B., Perez, M., Alcantara Luiz, V., Raimundo, J., Zambrano, L., Encina, J., Pereira Edimar, C., Bacci, M., Murad, N. and Fonseca, F. (2020) NGAL and Expression in the Early Detection of Diabetic Nephropathy by Liquid Biopsy. Journal of Clinical Pathology, 73, 713-721. https://doi.org/10.1136/jclinpath-2020-206494
|
[28]
|
Fu, W.-J., Xiong, S.-L., Fang, Y.-G., Wen, S., Chen, M.-L., Deng, R.-T., Zheng, L., Wang, S.-B., Pen, L.-F. and Wang, Q. (2012) Urinary Tubular Biomarkers in Short-Term Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study. Endocrine, 41, 82-88. https://doi.org/10.1007/s12020-011-9509-7
|